The biomarkers having the strongest discriminatory power amongst SS patients with or without ectopic salivary gland germinal centers were CCL11 (eotaxin) and IFN-γ, as well as BAFF/BLyS [35]. This evidence concerns the gene CCL11 and synovial sarcoma.